Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Cory Renauer - Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
The Motley Fool

Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN +0.75%), reported the sale of 5,222 ordinary shares for a total of approximately $143,000, as disclosed in a SEC Form 4 filing. MetricValueShares sold (direct)5,222Transaction…

thehindubusinessline.com - Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears
Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears
BusinessLine

Electronics could evolve from a rapidly growing export sector into the cornerstone of India's next manufacturing and export-led growth cycle, Yes Securities said, with Monte Carlo simulations showing a 55.2 per cent probability of generating a high…

thehindubusinessline.com - 'West Asia Crisis has impacted fertilisers and Pharma sectors', says Union Minister JP Nadda
'West Asia Crisis has impacted fertilisers and Pharma sectors', says Union Minister JP Nadda
BusinessLine

The Union Minister for Health and Family Welfare and Chemicals & Fertilisers, Jagat Prakash Nadda, said that the ongoing West Asia crisis has affected global supply chains linked to the fertiliser and pharmaceutical sectors, but assured that the…

marketbeat.com - Eventide Asset Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
Eventide Asset Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Eventide Asset Management LLC lessened its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 38.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund…

marketbeat.com - Fieldview Capital Management LLC Invests $3.74 Million in Royalty Pharma PLC $RPRX
Fieldview Capital Management LLC Invests $3.74 Million in Royalty Pharma PLC $RPRX
MarketBeat

Fieldview Capital Management LLC purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased…

marketbeat.com - Eventide Asset Management LLC Raises Stake in Royalty Pharma PLC $RPRX
Eventide Asset Management LLC Raises Stake in Royalty Pharma PLC $RPRX
MarketBeat

Eventide Asset Management LLC raised its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 41.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The…

marketbeat.com - First Turn Management LLC Has $28.11 Million Position in Ascendis Pharma A/S $ASND
First Turn Management LLC Has $28.11 Million Position in Ascendis Pharma A/S $ASND
MarketBeat

First Turn Management LLC lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 9.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 131,808 shares…

marketbeat.com - BridgeBio Pharma, Inc. $BBIO is Frazier Life Sciences Management L.P.'s 4th Largest Position
BridgeBio Pharma, Inc. $BBIO is Frazier Life Sciences Management L.P.'s 4th Largest Position
MarketBeat

Frazier Life Sciences Management L.P. lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…

theguardian.com - Julia Kollewe - London startup to trial drug to prevent cancer therapy side-effect 'cytokine storm'
London startup to trial drug to prevent cancer therapy side-effect 'cytokine storm'
The Guardian

A London-based startup is about to trial a drug at six NHS hospitals that could stop people on cancer immunotherapy getting a life-threatening side-effect. Poolbeg Pharma said its oral drug POLB 001 could make treatment for blood cancer safer by…

yahoo.com - Ramish Cheema - Jim Cramer Explains Johnson & Johnson's (JNJ) Shares Have Gained
Jim Cramer Explains Johnson & Johnson's (JNJ) Shares Have Gained
Yahoo!

Jim Cramer Didn't Hold Back On SpaceX's IPO & Discussed These 12 Stocks. Johnson & Johnson (NYSE:JNJ) is one of the stocks discussed by Jim Cramer. Johnson & Johnson (NYSE:JNJ)'s shares are up by 53% over the past year and by 15% year-to-date.

seekingalpha.com - Albert Anthony - Strawberry Fields REIT: A Growth And Dividend Idea Among Skilled-Nursing REITs (NYSE:STRW)
Strawberry Fields REIT: A Growth And Dividend Idea Among Skilled-Nursing REITs (NYSE:STRW)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

globaltimes.cn - Japanese drug firms reportedly expand in China; Tokyo urged to heed business community's calls to stabilize ties: expert
Japanese drug firms reportedly expand in China; Tokyo urged to heed business community's calls to stabilize ties: expert
Global Times

Japanese drug company Astellas Pharma will open a research and development (R&D) center in Beijing as soon as this year, which would be the company's first R&D center in China, aiming to tap the rapidly improving drug discovery capabilities of…

fortune.com - Mia Osmonbekov - Middle-aged adults taking GLP-1s for obesity can save $192K+ on lifetime medical costs, more if they don't have college degrees, new study finds
Middle-aged adults taking GLP-1s for obesity can save $192K+ on lifetime medical costs, more if they don't have college degrees, new study finds
Fortune

Over 40 million Americans have reported using GLP-1 drugs for weight loss, a behavior reshaping everything from the healthcare industry to pop culture and consumer behavior—and the drugs' use could balloon into as much as a $240 billion…

marketbeat.com - Teva Pharmaceutical Industries Ltd. $TEVA Stock Holdings Decreased by Avidity Partners Management LP
Teva Pharmaceutical Industries Ltd. $TEVA Stock Holdings Decreased by Avidity Partners Management LP
MarketBeat

Avidity Partners Management LP decreased its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 18.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional…

nypost.com - Geoff Earle - Exclusive | Influx of out-of-state agitators with links to dark money group among Delaney Hall arrests: 'Organized anarchy'
Exclusive | Influx of out-of-state agitators with links to dark money group among Delaney Hall arrests: 'Organized anarchy'
New York Post

An influx of out-of-state agitators — some hailing from elite backgrounds — were arrested in Newark during the chaotic standoff with law enforcement outside the Delaney Hall migrant detention center, The Post has learned. Out of the…

Receive a Daily briefing on Pharma Industry News

Get Started